The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/- phenotype

被引:64
作者
Chan, Wan Y. I.
Follows, George A.
Lacaud, Georges
Pimanda, John E.
Landry, Josette-Renee
Kinston, Sarah
Knezevic, Kathy
Piltz, Sandie
Donaldson, Ian J.
Gambardella, Laure
Sablitzky, Fred
Green, Anthony R.
Kouskoff, Valerie
Gottgens, Berthold
机构
[1] Univ Cambridge, Inst Med Res, Dept Haematol, Cambridge CB2 2XY, England
[2] Christie Hosp NHS Trust, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
D O I
10.1182/blood-2006-05-023226
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transcription factors are key regulators of hematopoietic stem cells (HSCs), yet the molecular mechanisms that control their expression are largely unknown. Previously, we demonstrated that expression of Scl/Tal1, a transcription factor required for the specification of HSCs, is controlled by Ets and GATA factors. Here we characterize the molecular mechanisms controlling expression of Lyl1, a paralog of Scl also required for HSC function. Two closely spaced promoters directed expression to hematopoietic progenitor, megakaryocytic, and endothelial cells in transgenic mice. Conserved binding sites required for promoter activity were bound in vivo by GATA-2 and the Ets factors Fill, Elf1, Erg, and PU.1. However, despite coregulation of Scl and Lyl1 by the same Ets and GATA factors, Scl expression was initiated prior to Lyl1 in embryonic stem (ES) cell differentiation assays. Moreover, ectopic expression of Scl but not Lyll rescued hematopoietic differentiation in Scl(-/-) ES cells, thus providing a molecular explanation for the vastly different phenotypes of Scl(-/-) and Lyl(-/-) mouse embryos. Furthermore, coregulation of Scl and Lyll later during development may explain the mild phenotype of Scl(-/-) adult HSCs.
引用
收藏
页码:1908 / 1916
页数:9
相关论文
共 50 条
[31]   Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia [J].
Meng, YS ;
Khoury, H ;
Dick, JE ;
Minden, MD .
LEUKEMIA, 2005, 19 (11) :1941-1947
[32]   Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene [J].
Mikkola, HKA ;
Klintman, J ;
Yang, HD ;
Hock, H ;
Schlaeger, TM ;
Fujiwara, Y ;
Orkin, SH .
NATURE, 2003, 421 (6922) :547-551
[33]   Specification of astrocytes by bHLH protein SCL in a restricted region of the neural tube [J].
Muroyama, Y ;
Fujiwara, Y ;
Orkin, SH ;
Rowitch, DH .
NATURE, 2005, 438 (7066) :360-363
[34]   GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription [J].
Nerlov, C ;
Querfurth, E ;
Kulessa, H ;
Graf, T .
BLOOD, 2000, 95 (08) :2543-2551
[35]   Diversification of haematopoietic stem cells to specific lineages [J].
Orkin, SH .
NATURE REVIEWS GENETICS, 2000, 1 (01) :57-64
[36]  
Porcher C, 1999, DEVELOPMENT, V126, P4603
[37]   The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages [J].
Porcher, C ;
Swat, W ;
Rockwell, K ;
Fujiwara, Y ;
Alt, FW ;
Orkin, SH .
CELL, 1996, 86 (01) :47-57
[38]   The proto-oncogene ERG in megakaryoblastic leukemias [J].
Rainis, L ;
Toki, T ;
Pimanda, JE ;
Rosenthal, E ;
Machol, K ;
Strehl, S ;
Göttgens, B ;
Ito, E ;
Izraeli, S .
CANCER RESEARCH, 2005, 65 (17) :7596-7602
[39]   The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse [J].
Robb, L ;
Elwood, NJ ;
Elefanty, AG ;
Kontgen, F ;
Li, RL ;
Barnett, LD ;
Begley, CG .
EMBO JOURNAL, 1996, 15 (16) :4123-4129
[40]  
Sabin F.R, 1920, CARNE CONTRIB EMBRYO, V272, P214